Meeting the biologic challenge of colorectal metastases.
about
Future directions for monitoring treatment response in colorectal cancerPan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cellsContrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal modelBeyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitroDysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo.Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cellsTriptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective studyLymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.MACC1 - a novel target for solid cancers.Impact of surgical margin clearance for resection of secondary hepatic malignancies.Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer.PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
P2860
Q27008428-41427CED-38C6-4935-BFB2-07FF290ECF50Q28542827-42F1F791-3059-4EC4-84AC-E976F3C1523AQ30413821-A7E260DA-81DC-47AB-85B6-1F83CC64B7F2Q35009440-4FBD8E45-A972-458F-8A21-C93BF054695CQ35551409-A1EB7AF8-7915-4A47-8EEE-560252893928Q35680721-A00B2362-946A-44FA-AC6C-1697164BD00DQ36559874-D39EF946-7093-47F4-AD57-3322582C5F8DQ37211609-FA7059B9-29F2-42A1-B10B-123F858094BEQ37277448-4E34B333-32F5-4DAB-80F0-A62DDB7D8E2FQ37587123-56D68A5D-B47D-4FE3-B957-AA8773577DEAQ37607246-CAAB3556-E79C-46D6-B9C2-2F59A468214AQ37608664-44153FEC-6A15-4052-B372-8655035F49B5Q38118345-AFE3B16C-6DC9-491B-B5C1-AD5ADACA03BFQ38667823-454FADDE-74A2-4433-B842-AEC4A4F54DA8Q38938329-76CA9FBA-D0A8-44B4-A1CE-AD997A79A6AFQ39119718-D59176AF-9342-460E-978D-47CEA3A2EDFFQ39708324-F766B342-1EE5-4D62-B4D4-0FCCB522793BQ41701933-EFD1262B-47F4-4F21-81D2-28C98058893BQ50911525-02D556CC-2CBA-43E5-949D-18DE5A4D0407Q54348724-ECA86CC2-A5F4-44BF-BBA4-3B81F4AE0A9FQ54962725-AB72CE34-3FF9-4D53-A12A-B9D22A9441D7
P2860
Meeting the biologic challenge of colorectal metastases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Meeting the biologic challenge of colorectal metastases.
@en
type
label
Meeting the biologic challenge of colorectal metastases.
@en
prefLabel
Meeting the biologic challenge of colorectal metastases.
@en
P2093
P2860
P1476
Meeting the biologic challenge of colorectal metastases.
@en
P2093
Harold J Wanebo
Mark LeGolvan
Markus Zuber
Michael I D'Angelica
Nancey E Kemeny
Philip B Paty
Sukamal Saha
P2860
P2888
P304
P356
10.1007/S10585-012-9517-X
P577
2012-10-10T00:00:00Z
P6179
1037274733